Aura Biosciences, Inc. (AURA) Stock Overview
Explore Aura Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Aura Biosciences, Inc. (AURA)
Key Financials
Key Financials
Market Cap
817.1M
P/E Ratio
-4.33
EPS (TTM)
$-1.74
ROE
-0.73%
AURA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Aura Biosciences, Inc. (NASDAQ: AURA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Aura Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of AURA on the NASDAQ shows an RSI of 54.96, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.32 for the NASDAQ listing.
Key metrics behind Aura Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -4.33 and a market capitalization of 817.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AURA on the NASDAQ.